Arteriosclerosis and Thrombosis, Vol 12, 736-744, Copyright © 1992 by American Heart Association
ARTICLES |
KR Marotti, CK Castle, RW Murray, EF Rehberg, HG Polites and GW Melchior
Molecular Biology Research and Metabolic Diseases Research, Upjohn Laboratories, Kalamazoo, MI 49001.
To assess the effects of cholesteryl ester transfer protein (CETP) on the primate lipoprotein profile, a transgenic mouse expressing cynomolgus monkey CETP was developed. The C57BL/6 mouse was used, and four lines expressing the primate CETP were established. The level of CETP activity in the plasma of the transgenic mice ranged from values similar to those obtained for the monkey to levels approximately sixfold higher than that in the normal monkey. When all of the lines were taken into consideration, there was a strong (r = -0.81 or higher, p less than 0.01) negative correlation between plasma CETP activity and total plasma cholesterol, plasma apolipoprotein (apo) A-I levels, and plasma apo A-I to apo B ratio. There was a strong positive correlation (r = 0.77) between plasma CETP activity and plasma apo B levels. The size of the apo A-I-containing lipoproteins was significantly reduced in mice with high plasma CETP activity, and that reduction in size was due to the absence of the larger (HDL1 and HDL2) apo A-I-containing particles in the plasma. When the transgenic mice were fed a high-fat, high-cholesterol diet, the effects of the diet on lipoprotein profile were more prominent in the CETP transgenic mice than the controls. The CETP transgenic mice had, for example, substantially higher plasma cholesterol and plasma apo B levels (p less than 0.01), and the apo B- containing lipoproteins were generally larger than those in the nontransgenic C57BL/6 mice consuming the same diet.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
Z. Zak, L. Lagrost, T. Gautier, D. Masson, V. Deckert, L. Duverneuil, J.-P. P. de Barros, N. Le Guern, L. Dumont, M. Schneider, et al. Expression of simian CETP in normolipidemic Fisher rats has a profound effect on large sized apoE-containing HDL J. Lipid Res., December 1, 2002; 43(12): 2164 - 2171. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Escolà-Gil, J. Julve, A. Marzal-Casacuberta, J. Ordóñez-Llanos, F. González-Sastre, and F. Blanco-Vaca ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance J. Lipid Res., February 1, 2001; 42(2): 241 - 248. [Abstract] [Full Text] |
||||
![]() |
S. Jansen, J. Lopez-Miranda, P. Castro, F. Lopez-Segura, C. Marin, J. M Ordovas, E. Paz, J. Jimenez-Pereperez, F. Fuentes, and F. Perez-Jimenez Low-fat and high-monounsaturated fatty acid diets decrease plasma cholesterol ester transfer protein concentrations in young, healthy, normolipemic men Am. J. Clinical Nutrition, July 1, 2000; 72(1): 36 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Plump, L. Masucci-Magoulas, C. Bruce, C. L. Bisgaier, J. L. Breslow, and A. R. Tall Increased Atherosclerosis in ApoE and LDL Receptor Gene Knock-Out Mice as a Result of Human Cholesteryl Ester Transfer Protein Transgene Expression Arterioscler Thromb Vasc Biol, April 1, 1999; 19(4): 1105 - 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Castle, S. L. Kuiper, W. L. Blake, B. Paigen, K. R. Marotti, and G. W. Melchior Remodeling of the HDL in NIDDM: a fundamental role for cholesteryl ester transfer protein Am J Physiol Endocrinol Metab, June 1, 1998; 274(6): E1091 - E1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, Y. L. Zhang, M. J. Spence, R. E. Vestal, P. M. Wallace, and D. S. Grass Liver LDL Receptor mRNA Expression Is Decreased in Human ApoB/CETP Double Transgenic Mice and Is Regulated by Diet as Well as the Cytokine Oncostatin M Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2948 - 2954. [Abstract] [Full Text] |
||||
![]() |
W. V. Rodrigueza, K. D. Mazany, A. D. Essenburg, M. E. Pape, T. J. Rea, C. L. Bisgaier, and K. J. Williams Large Versus Small Unilamellar Vesicles Mediate Reverse Cholesterol Transport In Vivo Into Two Distinct Hepatic Metabolic Pools : Implications for the Treatment of Atherosclerosis Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 2132 - 2139. [Abstract] [Full Text] |
||||
![]() |
J. A. Kuivenhoven, P. de Knijff, J. M.A. Boer, H. A. Smalheer, G.-J. Botma, J. C. Seidell, J. J.P. Kastelein, and P. H. Pritchard Heterogeneity at the CETP Gene Locus : Influence on Plasma CETP Concentrations and HDL Cholesterol Levels Arterioscler Thromb Vasc Biol, March 1, 1997; 17(3): 560 - 568. [Abstract] [Full Text] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |